Objective: To examine the association between weight loss during the first 10 days of life and the incidence of death or bronchopulmonary dysplasia (BPD) in small for gestational age (SGA) and appropriate for gestational age (AGA) extremely low-birth-weight infants.
Introduction
Bronchopulmonary dysplasia (BPD) is a common morbidity among extremely low-birth-weight (ELBW) infants. Despite the improving survival of ELBW infants 1 and intense search for new strategies to reduce its occurrence, the incidence of BPD remains largely unchanged.
Compared to term infants, ELBW infants have a higher body and extracellular water content. 2 During the first few days of life, they undergo a physiologic decrease in extracellular fluid (ECF) accompanied by early postnatal weight loss (EPWL). 3, 4 The physiologic contraction of ECF may not occur in preterm infants if inappropriately high fluid or sodium intakes are provided; this is reflected by a lack of EPWL. [4] [5] [6] One speculation is that the lack of EPWL may be associated with increased lung water and decreased pulmonary compliance. This may result in the need for greater ventilatory support and oxygen requirements, with subsequent development of lung injury and BPD. One of our hypothesis is that lack of EPWL is associated with an increase in the incidence of BPD among ELBW survivors.
Previous studies [7] [8] [9] have shown that small for gestational age (SGA) infants have a different body composition when compared with appropriate for gestational age (AGA) infants. Because SGA infants have less lean body mass and fat when expressed per kilogram body weight, their body water content is higher than their AGA counterparts. 10 SGA infants also have less EPWL than AGA infants. 7 How these differences in body composition and EPWL affect the association between EPWL and incidence of BPD is not known. Thus, our other hypothesis is that the association of BPD or death with lack of EPWL is different between SGA and AGA infants.
Subjects and methods
We retrospectively analyzed a cohort of 9461 ELBW infants admitted to 19 neonatal intensive care units in the NICHD-funded Neonatal Research Network (Appendix A) during calendar years 1994-2002. Data were collected by trained study nurses as part of the network's registry that includes infants with birth weight between 401 and 1500 g. We selected infants with a birth weight between 401 and 1000 g, and gestation between 24 and 29 weeks who survived beyond 72 h of age as our study subjects. The study infants were classified as SGA infants if birth weight was below 10th percentile according to Alexander et al.
11 criteria and AGA infants with birth weight between 10th and 90th percentile. Infants were further classified into EPWL group, if their weight fell below their birth weight anytime during the first 10 days of life, and no EPWL group, if their weight never fell below or exceeded their respective birth weights during the first 10 days. Infant's birth and daily body weights were obtained per routine practice of each Center using standard electronic scales.
Data on maternal and infant demographics and clinical characteristics were abstracted from their medical records. Trained research coordinators obtained the data based on the specific definition of each item listed in the Manual of Operations.
The outcomes of these infants were analyzed with reference to various maternal and neonatal demographic and clinical variables. The primary outcome was death before hospital discharge or BPD, the latter being defined as the need for supplemental oxygen at 36 weeks postconceptional age. We did not use the physiologic definition of BPD (oxygen restriction method) 12 because this method of data collection was not in place in the Network centers during the time period of this study. We used the composite outcome (death or BPD) as primary outcome since death is a competing variable for BPD.
Statistical analyses
The incidence of EPWL was compared between the AGA and SGA groups using w 2 test. The following statistical analyses were made for AGA and SGA infants separately. Maternal and infant demographic and clinical characteristics were analyzed comparing infants with EPWL to infants with no EPWL within each group. w 2 tests for categorical variables and Wilcoxon tests for continuous variables were used to test for differences. Logistic regression was performed to determine the association of EPWL with our primary outcome (death or BPD), controlling for various maternal and neonatal factors that were significantly different between the two groups. The variables that were included in the model for both AGA and SGA infants included maternal pre-eclampsia, prenatal antibiotic therapy, antenatal steroids, birth weight, gestation, male gender, surfactant usage, respiratory support (days on ventilation plus days on continuous positive airway pressure (CPAP)), early indomethacin therapy, patent ductus arteriosus (PDA) and center variations. Birth weight was divided by 100, so the odds ratio (OR) represents a 100 g increase in birth weight. These analyses were then performed for all ELBW infants, including the SGA status in the model. RTI International performed the statistical analyses. P<0.01 was considered significant because of multiple comparisons in the univariate analysis listed in Tables 1 and 2 .
Results
Of the 9461 ELBW infants who were eligible for the study, 1248 were SGA and 8213 were AGA. EPWL occurred in 81.2% of SGA infants compared with 93.7% of AGA infants (P<0.001).
The maternal characteristics of study infants are shown in Table 1 . Among AGA infants, all characteristics were similar between infants with EPWL and those without EPWL except for the incidence of maternal pre-eclampsia/hypertension, which was higher and usage of antenatal steroids and antibiotics which were lower in the group without EPWL. Among the SGA infants no difference was observed between those with or without EPWL. Table 2 shows the data on infants' characteristics and outcomes. EPWL infants in the AGA group had a lower gestational age, higher mean birth weight, were less likely to be male and outborn. A lower percentage of infants in the EPWL group had low Apgar score (<3) at 1 and 5 min. These infants had longer duration of respiratory support and were less likely to receive at least one dose of surfactant. Multiple gestation, early prophylactic indomethacin therapy (at less than 24 h of life), incidence of PDA and postnatal steroid administration rate was similar in the two groups. The incidence of BPD (47.2 vs 64%, P<0.001), death (13.8 vs 32.9%, P<0.001) and death or BPD (53.4 vs 74.3%, P<0.001) were lower in the group with EPWL.
Among SGA infants, those with EPWL had higher gestation and birth weight and had a lower incidence of low Apgar score at 1 min but not at 5 min. They were less likely to receive surfactant and had a lower incidence of PDA. There was no difference in gender distribution, outborn status, multiple gestation, duration of respiratory support, use of prophylactic indomethacin and postnatal steroids. The incidence of BPD (48.3 vs 62.1%, P=0.002), death (19 vs 40.8%, P<0.001) and death or BPD (55.9 vs 75.2%, P<0.001) were lower among the group of infants with EPWL.
Logistic regression analysis (Table 3) , controlling for maternal and infant demographic and clinical characteristics that were shown to be different by univariate analysis, showed that EPWL was still associated with a decreased risk of death or BPD for both AGA (OR 0.47, 95% CI: 0.37-0.60) and SGA infants (OR 0.60, 95% CI: 0.41-0.89). Other variables that were significantly associated with death or BPD included pre-eclampsia and higher birth weight (lower risk) and male gender, longer respiratory support, surfactant use, and presence of PDA. These associations were true for both AGA and SGA groups. Site was also included in this model to control for any center differences in outcomes (data not shown). On analyzing all AGA and SGA infants collectively by regression analyses in relation to death or BPD by including SGA status 
Discussion
In this retrospective cohort study, we showed that weight loss in ELBW infants during the first 10 days was seen less often in SGA infants as compared with AGA infants. This finding with a much larger sample size in our study confirms the previous observation by Bauer et al.
7
Using indicator dilution techniques, several studies have shown a higher total body fluid content in the SGA infants when compared with their AGA counterparts. [7] [8] [9] This observation is consistent with the notion that in intrauterine growth restricted or SGA infants, the higher body water content is due to a lower lean body mass and fat content when expressed as percent birth weight. 10 Thus, it is somewhat counterintuitive to have a lower incidence of EPWL in SGA infants since the expectation is that a larger body fluid content 3, 4 would result in more fluid loss after birth with greater accompanying weight loss. Alternatively, it has been suggested that SGA infants' postnatal weight loss is owing to catabolism rather than fluid loss, 9 in part due to their higher metabolic rate. 13, 14 Thus, the reason(s) for the difference in the incidence of EPWL between SGA and AGA remains unknown and needs further investigation.
The clinical relevance of this study is as follows: in view of the different body composition and documented difference in the magnitude of EPWL, clinicians might wonder whether SGA infants have a different association between EPWL and incidence of BPD among ELBW survivors. Our data show that the association is similar between the two groups of infants, despite the difference in their body composition. Thus, in interpreting EPWL with reference to the risk for BPD, clinicians should disregard the AGA/SGA status of the infant. It is apparent from previous studies that excessive fluid intake is associated with increased incidence of PDA 15, 16 necrotizing enterocolitis 17 as well as BPD. [18] [19] [20] [21] Since appropriate amount of fluid intake is associated with physiologic contraction of ECF and weight loss, attention to weight changes assuring appropriate percentage of weight loss would be an important clinical exercise to minimize the occurrence of various neonatal morbidities.
Our study's weakness is that the data were collected as a set of generic database of all ELBW infants admitted to the Network's centers and were analyzed retrospectively. Thus, some of the pertinent information such as precise daily weight loss, the postnatal age at which weight loss was seen, and fluid and electrolyte intakes were not recorded and were not available.
In summary, we found a significantly lower incidence of EPWL among SGA infants when compared with their AGA counterparts. This difference in weight loss did not affect the association between weight loss and incidence of BPD between AGA and SGA ELBW survivors. In using weight loss as a marker of appropriate fluid balance, clinicians should disregard the AGA or SGA status of the infants under consideration. Abbreviations: AGA, appropriate for gestational age; BPD, bronchopulmonary dysplasia; ELBW, extremely low-birth-weight; EPWL, early postnatal weight loss; SGA, small for gestational age.
